Enhancer ID: | E_02_0020 |
Species: | mouse |
Position : | chr13:83649881-83651881 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Impaired myogenic differentiation potential |
Pubmed ID: | 29245050 |
Enhancer experiment: | Western blot,Immunohistochemical Staining,qPCR |
Enhancer experiment description: | Interestingly, senescence and NANOG had dramatic effect on the expression level of Mef2c, which regulates myoblast proliferation by exercising transcriptional control of cell cycle related genes |
Target gene : | Mef2c(5430401D19Rik,9930028G15Rik,AV011172,Mef2) |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | Interestingly, senescence and NANOG had dramatic effect on the expression level of Mef2c, which regulates myoblast proliferation by exercising transcriptional control of cell cycle related genes |
TF name : | -- |
TF experiment: | Western blot,Immunohistochemical Staining,qPCR |
TF experiment description: | Interestingly, senescence and NANOG had dramatic effect on the expression level of Mef2c, which regulates myoblast proliferation by exercising transcriptional control of cell cycle related genes |
Enhancer function : | Interestingly, senescence and NANOG had dramatic effect on the expression level of Mef2c, which regulates myoblast proliferation by exercising transcriptional control of cell cycle related genes |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
Interestingly, senescence and NANOG had dramatic effect on the expression level of Mef2c, which regulates myoblast proliferation by exercising transcriptional control of cell cycle related genes |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|